1,329
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

The insight of in vitro and in silico studies on cholinesterase inhibitors from the roots of Cimicifuga dahurica (Turcz.) Maxim.

, , , , , , & show all
Pages 1174-1180 | Received 10 Apr 2018, Accepted 19 Jun 2018, Published online: 05 Oct 2018

References

  • Orhan IE, Senol FS, Shekfeh S, et al. Pteryxin-A promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea. Food Chem Toxicol 2017;109:970–4.
  • Zhang X-J, Greenberg D. Acetylcholinesterase involvement in apoptosis. Front Mol Neurosci 2012;5:1–6.
  • Dvir H, Silman I, Harel M, et al. Acetylcholinesterase: From 3D structure to function. Chem Biol Interact 2010;187:10–22.
  • Ali R, Sheikh IA, Jabir NR, Kamal MA. Comparative review of decade’s research on cholinesterase inhibition. Am J Neuroprot Neuroregen 2012;4:136–8.
  • Nguyen VTN, Zhao BT, Seong SH, et al. Inhibitory effects of serratene-type triterpenoids from Lycopodium complanatum on cholinesterases and β-secretase 1. Chem Biol Interact 2017;274:150–7.
  • Huang Y-J, Huang Y, Baldassarre H, et al. Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoing. Pro Natl Acad Sci USA 2007;104:13603–8.
  • de Souza LG, Rennã MN, Figueroa-Villar JD. Coumarins as cholinesterase inhibitors: A review. Chem Biol Interact 2016;254:11–23.
  • Islam MM, Rohman MA, Gurung AB, et al. Correlation of cholinergic drug induced quenching of acetylcholinesterase bound thioflavon-T fluorescence with their inhibition activity. Spectrochim Acta A 2018;189:250–7.
  • Lv C, Yang F, Qin R, et al. Bioactivity-guided isolation of chemical constituents against H2O2-induced neurotoxicity on PC12 from Cimicifuga dahurica (Turcz.) Maxim. Bioorg Med Chem Lett 2017;27:3305–9.
  • Tian Z, Si J, Chang Q, et al. Antitumor activity and mechanisms of action of total glycosides from aerial part of Cimicifuga dahurica targeted against hepatoma. BMC Cancer 2007;7:7–10.
  • Qin R, Zhao Y, Zhao Y, et al. Polyphenolic compounds with antioxidant potential and neuro-protective effect from Cimicifuga dahurica (Turcz.) Maxim. Fitoterapia 2016;115:52–6.
  • Othman WNNW, Liew SY, Khaw KY, et al. Cholinesterase inhibitory activity of isoquinoline alkaloids from three Cryptocarya species (Lauraceae). Bioorg Med Chem 2016;24:4464–9.
  • Thao NP, Luyen BTT, Lee JS, et al. Soluble epoxide hydrolase inhibitors of indolinone alkaloids and phenolic derivatives from Cimicifuga dahurica (Turcz.) Maxim. Bioorg Med Chem Lett 2017;27:1874–9.
  • Kusano A, Takahira M, Shibano M, et al. Studies on the Constituents of Cimicifuga Species. XXVI. Twelve New Cyclolanostanol Glycosides from the Underground Parts of Cimicifuga simplex WORMSK. Chem Pharm Bull 1999;47:511–6.
  • Thao NP, Kim JH, Luyen BTT, et al. In silico investigation of cycloartane triterpene derivatives from Cimicifuga dahurica (Turcz.) Maxim roots for the development of potent soluble epoxide hydrolase inhibitors. Inter J Biol Macromole 2017;98:526–34.
  • Li JX, Kadota S, Hattori M, et al. Constituents of Cimicifugae Rhizoma. I. Isolation and Characterization of Ten New Cycloartenol Triterpenes from Cimicifuga heracleifolia KOMAROV. Chem Pharm Bull 1993;41:832–41.
  • Thao NP, Luyen BT, Lee JS, et al. Inhibition potential of cycloartane-type glycosides from the roots of Cimicifuga dahurica against soluble epoxide hydrolase. J Nat Prod 2017;80:1867–75.
  • Imai A, Lankin DC, Nikolić D, et al. Cycloartane triterpenes from the aerial parts of Actaea racemosa. J Nat Prod 2016;79:541–54.
  • Yoshimitsu H, Nishida M, Sakaguchi M, Nohara I. Two new 15-deoxycimigenol-type and three new 24-epi-cimigenol-type glycosides from Cimicifuga rhizome. Chem Pharm Bull 2006;54:1322–5.
  • Groner E, Ashani Y, Schorer-Apelbaum D, et al. The kinetics of Inhibition of Human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates. Mol Pharmacol 2007;71:1610–7.
  • Jiang Y, Gao H, Turdu G. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer’s disease: A review. Bioorg Chem 2017;75:50–61.
  • Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab 2012;32:1959–72.
  • Grabrucker AM, Ruozi B, Belletti D, et al. Nanoparticle transport across the blood brain barrier. Tissue Barriers 2016; 4:e1153568–19.